Literature DB >> 22427204

Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency.

Rachel K Shaw1, Andrew C Issekutz, Robert Fraser, Pierre Schmit, Barb Morash, Linda Monaco-Shawver, Jordan S Orange, Conrad V Fernandez.   

Abstract

EBV-associated smooth muscle tumors are found in immunocompromised patients, most commonly HIV/AIDS. We present a 12-year-old girl with the first documented case of EBV-related smooth muscle tumors in the presence of a rare classic NK cell deficiency. This sheds light on the role of NK cells in controlling EBV-related smooth muscle tumors.

Entities:  

Mesh：

Year:  2012        PMID： 22427204      PMCID： PMC3350365          DOI： 10.1182/blood-2011-10-385377

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  18 in total

1.  IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway.

Authors:  Hyunkeun Song; Hyunjin Park; Jiyoung Kim; Gabin Park; Yeong-Seok Kim; Sung Mok Kim; Daejin Kim; Su Kil Seo; Hyun-Kyung Lee; DaeHo Cho; Daeyoung Hur
Journal:  Immunol Lett       Date:  2011-01-26       Impact factor: 3.685

2.  Epstein-Barr virus-associated smooth muscle tumors in ataxia-telangiectasia: a case report and review.

Authors:  Christine Reyes; Omar Abuzaitoun; Andrew De Jong; Celine Hanson; Claire Langston
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

3.  Epstein-Barr virus--an old dog with new tricks.

Authors:  D Liebowitz
Journal:  N Engl J Med       Date:  1995-01-05       Impact factor: 91.245

4.  Bilateral smooth-muscle tumors of the adrenals in a child with AIDS.

Authors:  D L Rosenfeld; W S Girgis; S J Underberg-Davis
Journal:  Pediatr Radiol       Date:  1999-05

5.  Epstein-Barr virus-associated leiomyosarcoma of the thyroid in a child with congenital immunodeficiency: a case report.

Authors:  A Tulbah; F Al-Dayel; I Fawaz; J Rosai
Journal:  Am J Surg Pathol       Date:  1999-04       Impact factor: 6.394

Review 6.  Natural killer cell responses to viral infection.

Authors:  Joshua D Brandstadter; Yiping Yang
Journal:  J Innate Immun       Date:  2011-03-12       Impact factor: 7.349

Review 7.  Human natural killer cell deficiencies.

Authors:  Jordan S Orange
Journal:  Curr Opin Allergy Clin Immunol       Date:  2006-12

Review 8.  Primary adrenal leiomyosarcoma in a man with acquired immunodeficiency syndrome (AIDS). Further evidence for an increase in smooth muscle tumors related to Epstein-Barr infection in AIDS.

Authors:  P J Zetler; J D Filipenko; J H Bilbey; N Schmidt
Journal:  Arch Pathol Lab Med       Date:  1995-12       Impact factor: 5.534

9.  The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

Authors:  E S Lee; J Locker; M Nalesnik; J Reyes; R Jaffe; M Alashari; B Nour; A Tzakis; P S Dickman
Journal:  N Engl J Med       Date:  1995-01-05       Impact factor: 91.245

10.  Multifocal Epstein-Barr virus-associated smooth muscle tumor in adults with AIDS: case report and review of the literature.

Authors:  S Gallien; B Zuber; M Polivka; M Lagrange-Xelot; J-B Thiebault; P Bertheau; F Gray; J-M Molina
Journal:  Oncology       Date:  2008-08-20       Impact factor: 2.935
View more
  27 in total

Review 1.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

Review 2.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 3.  The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.

Authors:  Olivia L Hatton; Aleishia Harris-Arnold; Steven Schaffert; Sheri M Krams; Olivia M Martinez
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

4.  Imaging findings in children with proliferative disorders following multivisceral transplantation.

Authors:  Anastasia L Hryhorczuk; Heung Bae Kim; Marian H Harris; Sara O Vargas; David Zurakowski; Edward Y Lee
Journal:  Pediatr Radiol       Date:  2015-03-22

5.  Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.

Authors:  Alexander Vargas-Hernández; Emily M Mace; Ofer Zimmerman; Christa S Zerbe; Alexandra F Freeman; Sergio Rosenzweig; Jennifer W Leiding; Troy Torgerson; Matthew C Altman; Edith Schussler; Charlotte Cunningham-Rundles; Ivan K Chinn; Alexandre F Carisey; Imelda C Hanson; Nicholas L Rider; Steven M Holland; Jordan S Orange; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

6.  Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection.

Authors:  Obinna Chijioke; Anne Müller; Regina Feederle; Mario Henrique M Barros; Carsten Krieg; Vanessa Emmel; Emanuela Marcenaro; Carol S Leung; Olga Antsiferova; Vanessa Landtwing; Walter Bossart; Alessandro Moretta; Rocio Hassan; Onur Boyman; Gerald Niedobitek; Henri-Jacques Delecluse; Riccarda Capaul; Christian Münz
Journal:  Cell Rep       Date:  2013-12-19       Impact factor: 9.423

Review 7.  Review of the Literature on Leiomyoma and Leiomyosarcoma of the Adrenal Gland: A Systematic Analysis of Case Reports.

Authors:  Maria Sakellariou; Dionysios Dellaportas; Melpomeni Peppa; Dimitrios Schizas; Emmanouil Pikoulis; Konstantinos Nastos
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

8.  A distinct subpopulation of human NK cells restricts B cell transformation by EBV.

Authors:  Anna Lünemann; Liliana D Vanoaica; Tarik Azzi; David Nadal; Christian Münz
Journal:  J Immunol       Date:  2013-10-09       Impact factor: 5.422

Review 9.  Innate immune responses against Epstein Barr virus infection.

Authors:  Obinna Chijioke; Tarik Azzi; David Nadal; Christian Münz
Journal:  J Leukoc Biol       Date:  2013-06-28       Impact factor: 4.962

10.  Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

Authors:  Emily M Mace; Amy P Hsu; Linda Monaco-Shawver; George Makedonas; Joshua B Rosen; Lesia Dropulic; Jeffrey I Cohen; Eugene P Frenkel; John C Bagwell; John L Sullivan; Christine A Biron; Christine Spalding; Christa S Zerbe; Gulbu Uzel; Steven M Holland; Jordan S Orange
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.